Germany Rules CBD a ‘Novel Food.’ Can the US Catch Up With Regulation?
Earlier this week, Court officials in Germany established the classification for CBD (cannabidiol) as a novel food. This was done following the ruling with the European Union, which previously ruled that products with CBD cannot be marketed without additional safety research.
This is a classification for something that has no evidence of being consumed on a large scale before May of 1977.
This doesn’t mean that CBD cannot be sold anywhere in the EU, there is just a necessity of authorization.
This has posed some complications. The European Industrial Hemp Association challenged the fact that foods based from hemp had been used for centuries, and that the overall concept of hemp isn’t new, and neither are its numerous uses. An appeal has been made, but still pending.
How Can the US Compare?
It seems yet again that the EU is a few steps ahead in the game of regulation. Whereas, in the US, consumers are worried about frequent snake oil issues, as well as unsafe regulation practices.
There have been a few cases of people being arrested for the possession of CBD oil, simply because there was no regulation on the product in the first place to prove its validity. Validity being the upholding of the .3% THC limitation.
With that, consumers are also concerned if the product they’re buying really does abide by that law, or if their product could get them a resulting failed drug test.
There have been movements, however, such as the Farm Bill passing, as well as the rescheduling of CBD. Hemp is a legal cash crop now, and more research is being done on the cannabinoid system to help move this process along.
If you want to stay tuned with CBD news, consider signing up for our newsletter!